Imaging of MMP activity in postischemic cardiac remodeling using radiolabeled MMP-2/9 activatable peptide probes

Molecular Pharmaceutics

Volumn 11, Issue 5, 2014, Pages 1415-1423

  Van Duijnhoven, Sander M J ^a,b   Robillard, Marc S ^b,c   Hermann, Sven ^d   Kuhlmann, Michael T ^d   Schäfers, Michael ^d   Nicolay, Klaas ^a,b   Grüll, Holger ^a,b,c  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b Center for Imaging Research and Education (CIRE)   (Netherlands)

^c PHILIPS RESEARCH LABORATORIES   (Netherlands)

^d INST OF REPRO MED OF THE UNIV   (Germany)

Author keywords

activatable imaging probes; matrix metalloproteinases; molecular imaging; myocardial infarction; myocardial remodeling; radioisotopes

Indexed keywords

CELL PENETRATING PEPTIDE; GELATIN; GELATINASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MOLECULAR PROBE; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CARDIAC IMAGING; CONTROLLED STUDY; ENZYME ACTIVITY; HEART; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE; IN VIVO STUDY; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SWISS WEBSTER MOUSE; ZYMOGRAPHY; ANIMAL; CHEMISTRY; DIAGNOSTIC USE; DISEASE MODEL; MALE; METABOLISM; MOLECULAR PROBE;

ANIMALS; DISEASE MODELS, ANIMAL; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MICE; MOLECULAR PROBES; MYOCARDIAL INFARCTION; MYOCARDIUM; PEPTIDES;

EID: 84899893785     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400569k     Document Type: Article

References (25)

1. Deschamps, A. M.; Spinale, F. G. Pathways of matrix metalloproteinase induction in heart failure: Bioactive molecules and transcriptional regulation Cardiovasc. Res. 2006, 69, 666-676
2. Vanhoutte, D.; Schellings, M.; Pinto, Y.; Heymans, S. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window Cardiovasc. Res. 2006, 69, 604-613
3. Zavadzkas, J. A.; Plyler, R. A.; Bouges, S.; Koval, C. N.; Rivers, W. T.; Beck, C. U.; Chang, E. I.; Stroud, R. E.; Mukherjee, R.; Spinale, F. G. Cardiac-restricted overexpression of extracellular matrix metalloproteinase inducer causes myocardial remodeling and dysfunction in aging mice Am. J. Physiol. Heart Circ. Physiol. 2008, 295, H1394-H1402
4. Mukherjee, R.; Mingoia, J. T.; Bruce, J. A.; Austin, J. S.; Stroud, R. E.; Escobar, G. P.; McClister, D. M., Jr.; Allen, C. M.; Alfonso-Jaume, M. A.; Fini, M. E.; Lovett, D. H.; Spinale, F. G. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction Am. J. Physiol. Heart Circ. Physiol. 2006, 291, H2216-H2228
5. Sahul, Z. H.; Mukherjee, R.; Song, J.; McAteer, J.; Stroud, R. E.; Dione, D. P.; Staib, L.; Papademetris, X.; Dobrucki, L. W.; Duncan, J. S.; Spinale, F. G.; Sinusas, A. J. Targeted imaging of spatial and temporal variation of matrix metalloproteinase activity in porcine model of post-infarct remodeling: relationship to myocardial dysfunction Circ. Cardiovasc. Imaging 2011, 4, 381-391
6. Chen, J.; Tung, C. H.; Allport, J. R.; Chen, S.; Weissleder, R.; Huang, P. L. Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction Circulation 2005, 111, 1800-1805
7. Jaffer, F. A.; Vinegoni, C.; John, M. C.; Aikawa, E.; Gold, H. K.; Finn, A. V.; Ntziachristos, V.; Libby, P.; Weissleder, R. Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis Circulation 2008, 118, 1802-1809
8. van Duijnhoven, S. M. J.; Robillard, M. S.; Nicolay, K.; Grüll, H. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation J. Nucl. Med. 2011, 52, 279-286
9. Jiang, T.; Olson, E. S.; Nguyen, Q. T.; Roy, M.; Jennings, P. A.; Tsien, R. Y. Tumor imaging by means of proteolytic activation of cell-penetrating peptides Proc. Nat. Acad. Sci. U.S.A. 2004, 101, 17867-17872
10. Tijink, B. M.; Laeremans, T.; Budde, M.; Stigter-van Walsum, M.; Dreier, T.; de Haard, H. J.; Leemans, C. R.; van Dongen, G. A. Improved tumor targeting of anti-epidermal growth factor receptor nanobodies through albumin binding: taking advantage of modular nanobody technology Mol. Cancer. Ther. 2008, 7, 2288-2297
11. van den Bosch, S. M.; Rossin, R.; Renart Verkerk, P.; ten Hoeve, W.; Janssen, H. M.; Lub, J.; Robillard, M. S. Evaluation of strained alkynes for Cu-free click reaction in live mice Nucl. Med. Biol. 2013, 40, 415-423
12. Guide for the Care and Use of Laboratory Animals. NIH, Government Printing Office: Washington, DC, 1985; pp 86-23.
13. Lutgens, E.; Daemen, M.; de Muinck, E. D.; Debets, J.; Leenders, P.; Smits, J. F. Chronic myocardial infarction in the mouse: cardiac structural and functional changes Cardiovasc. Res. 1999, 41, 586-593
14. Peeples, E. S.; Schopfer, L. M.; Duysen, E. G.; Spaulding, R.; Voelker, T.; Thompson, C. M.; Lockridge, O. Albumin, a new biomarker of organophosphorus toxicant exposure, identified by mass spectrometry Toxicol. Sci. 2005, 83, 303-312
15. Rudman, D.; Kendall, F. E. Bile acid content of human serum. II. The binding of cholanic acids by human plasma proteins J. Clin. Invest. 1957, 36, 538-542
16. 3H]palmitate to BSA Am. J. Physiol. Gastrointest. Liver Physiol. 1998, 275, G638-G644
17. Ruxton, G. D. The unequal variance t-test is an underused alternative to Student's t-test and the Mann-Whitney U test Behav. Ecol. 2006, 17, 688-690
18. Riches, A. C.; Sharp, J. G.; Brynmor Thomas, D.; Vaughan Smith, S. Blood volume determination in the mouse J. Physiol. 1973, 228, 279-284
19. Durbin, P. W.; Jeung, N.; Kullgren, B.; Clemons, G. K. Gross composition and plasma and extracellular water volumes of tissues of a reference mouse Health Phys. 1992, 63, 427-442
20. Su, H.; Spinale, F. G.; Dobrucki, L. W.; Song, J.; Hua, J.; Sweterlitsch, S.; Dione, N. P.; Cavaliere, P.; Chow, C.; Boruke, B. N.; Hu, X. Y.; Azure, M.; Yalamanchili, P.; Liu, R.; Cheesman, E. H.; Robinson, S.; Edwards, D. S.; Sinusas, A. J. Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling Circulation 2005, 112, 3157-3167
21. Xia, Z.; Xing, Y.; Jeon, J.; Kim, Y. P.; Gall, J.; Dragulescu-Andrasi, A.; Gambhir, S. S.; Rao, J. Immobilizing reporters for molecular imaging of the extracellular microenvironment in living animals ACS Chem. Biol. 2011, 6, 1117-1126
22. Fertin, M.; Lemesle, G.; Turkieh, A.; Beseme, O.; Chwastyniak, M.; Amouyel, P.; Bauters, C.; Pinet, F. Serum MMP-9: A novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction PLoS ONE 2013, 8, e71280
23. Spinale, F. G.; Mukherjee, R.; Zavadzkas, J. A.; Koval, C. N.; Bouges, S.; Stroud, R. E.; Dobrucki, L. W.; Sinusas, A. J. Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction J. Biol. Chem. 2010, 285, 30316-30327
24. Koenig, G. C.; Rowe, R. G.; Day, S. M.; Sabeh, F.; Atkinson, J. J.; Cooke, K. R.; Weiss, S. J. MT1-MMP-dependant remodeling of cardiac extracellular matrix structure and function following myocardial infarction Am. J. Pathol. 2012, 180, 1863-1878
25. Watkins, G. A.; Jones, E. F.; Scott Shell, M.; VanBrocklin, H. F.; Pan, M. H.; Hanrahan, S. M.; Feng, J. J.; He, J.; Sounni, N. E.; Dill, K. A.; Contag, C. H.; Coussens, L. M.; Franc, B. L. Development of an optimized activatable MMP-14 targeted SPECT imaging probe Bioorg. Med. Chem. 2009, 17, 653-659